Vivani Medical宣布,在与诺和诺德(Novo Nordisk)达成的协议中,并未包含针对Npm-139或其专有Nanoportal技术的任何排他性条款。这意味着,Vivani Medical仍可自由地将相关技术或产品授权给其他合作伙伴。
Vivani Medical宣布,在与诺和诺德(Novo Nordisk)达成的协议中,并未包含针对Npm-139或其专有Nanoportal技术的任何排他性条款。这意味着,Vivani Medical仍可自由地将相关技术或产品授权给其他合作伙伴。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.